My Tiny Feed

theguardian.com

Lithium's Declining Use in Bipolar Disorder Treatment

A discussion about the declining use of lithium in treating bipolar disorder despite its proven effectiveness, exploring controversies, research, and patient experiences.

Read original article in English

English

United Kingdom

HealthControversyMental HealthResearchTreatmentMedication

Oxford UniversityBen-Gurion University Of The NegevKing's College LondonUniversity College LondonBipolar Uk

Rebecca WildeGin S MalhiHaim BelmakerAllan YoungJoseph HayesSimon KitchenMichael GitlinCarol Crean

What triggered Rebecca Wilde's manic episode and subsequent bipolar disorder diagnosis?: Rebecca Wilde, a 32-year-old tech worker, experienced a severe manic episode due to work and family pressures, leading to a bipolar 1 disorder diagnosis.
What is the main controversy surrounding the use of lithium in treating bipolar disorder?: The controversy surrounds lithium's declining use, with some advocating for it as a first-line treatment while others express concerns about its side effects and management.
What are researchers currently exploring regarding lithium and its potential applications?: Researchers are exploring new methods for lithium monitoring, such as wearable sensors, and investigating its potential uses in treating suicide, dementia, and as a microdose supplement.
Why is the use of lithium declining despite its effectiveness in treating bipolar disorder?: Lithium, despite its effectiveness, is declining in popularity due to cumbersome management, potential side effects, and the rise of alternative medications.
What is Rebecca Wilde's perspective on lithium treatment and its role in her overall well-being?: While lithium has proven effective for Wilde, she acknowledges its limitations and the importance of a holistic approach including therapy, work-life balance, and support systems.

Jan 23, 10:08

Trump Launches \$500 Billion AI Project to Cure Cancer

President Trump launched Project Stargate, a \$500 billion AI-driven initiative to develop personalized mRNA cancer vaccines, aiming to detect and treat early-stage cancers through AI-powered blood tests and rapid vaccine production within 48 hours, despite concerns about public and political resistance.

Jan 23, 01:10

Microplastics Linked to Brain Blood Clots, Raising Dementia and Stroke Risks

A Peking University study reveals microplastics in the brain trigger immune responses, causing blood clots that may lead to stroke, depression, and possibly dementia; further research is needed.

Jan 23, 01:10

Rare Gene Mutation Linked to Late-Onset Alzheimer's

A study of an Italian family with six members affected by late-onset Alzheimer's disease reveals a rare mutation in the GRIN2C gene as a probable cause, offering a significant advancement in understanding the disease's genetic basis.

Jan 23, 01:10

Danish Medical Data Breach Exposes 130,000 Patient Records

A data breach at a Danish medical practice group exposed the sensitive information of 130,000 patients, including names, addresses, national identification numbers, and treatment protocols, nearly a month after the initial cyberattack, sparking public outrage over the delayed notification.